4DMT to Participate in Upcoming Investor Conferences

4DMT to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today…

#Pharming Group Sets Stage for Growth Investor Conferences on the Horizon,

Unlocking Opportunities: Pharming Group Gears Up for Investor Engagement in April As Pharming Group N.V., a prominent player in the biopharmaceutical industry, positions itself for significant investor interactions in April, analysts and stakeholders are keenly observing its roadmap. Headquartered in the Netherlands and listed on both Euronext Amsterdam and Nasdaq, Pharming's recent announcements signal a strategic push to strengthen its market …